References
- Assmus B, Fischer-Rasokat U, Honold J, Seeger FH, Fichtlscherer S, Tonn T, . Transcoronary transplantation of functionally competent BMCs is associated with a decrease in natriuretic peptide serum levels and improved survival of patients with chronic postinfarction heart failure: results of the TOPCARE-CHD Registry. Circ Res. 2007;100:1234–41.
- Iso Y, Spees JL, Serrano C, Bakondi B, Pochampally R, Song YH, . Multipotent human stromal cells improve cardiac function after myocardial infarction in mice without long-term engraftment. Biochem Biophys Res Commun. 2007;354:700–6.
- Balsam LB, Wagers AJ, Christensen JL, Kofidis T, Weissman IL, Robbins RC. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature. 2004;428:668–73.
- Fujita J, Mori M, Kawada H, Ieda Y, Tsuma M, Matsuzaki Y, . Administration of granulocyte colony-stimulating factor after myocardial infarction enhances the recruitment of hematopoietic stem cell-derived myofibroblasts and contributes to cardiac repair. Stem Cells. 2007;25:2750–9.
- Murry CE, Soonpaa MH, Reinecke H, Nakajima H, Nakajima HO, Rubart M, . Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature. 2004;428:664–8.
- Nygren JM, Jovinge S, Breitbach M, Sawen P, Roll W, Hescheler J, . Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat Med. 2004;10:494–501.
- Kawada H, Fujita J, Kinjo K, Matsuzaki Y, Tsuma M, Miyatake H, . Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction. Blood. 2004;104:3581–7.
- Schmidt-Lucke C, Rossig L, Fichtlscherer S, Vasa M, Britten M, Kamper U, . Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation. 2005;111:2981–7.
- Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, . Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med. 2005;353:999–1007.
- Kurdi M, Booz GW. G-CSF-based stem cell therapy for the heart: unresolved issue. A. Paracrine actions, mobilization, and delivery. Congest Heart Fail. 2007;13:221–7.
- Pitchford SC, Furze RC, Jones CP, Wengner AM, Rankin SM. Differential mobilization of subsets of progenitor cells from the bone marrow. Cell Stem Cell. 2009;4:62–72.
- Peister A, Mellad JA, Wang M, Tucker HA, Prockop DJ. Stable transfection of MSCs by electroporation. Gene Ther. 2004;11:224–8.
- Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M, . Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood. 2000;95:952–8.
- Rohde E, Bartmann C, Schallmoser K, Reinisch A, Lanzer G, Linkesch W, . Immune cells mimic the morphology of endothelial progenitor colonies in vitro. Stem Cells. 2007; 25:1746–52.
- Massa M, Rosti V, Ferrario M, Campanelli R, Ramajoli I, Rosso R, . Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. Blood. 2005;105:199–206.
- Wojakowski W, Tendera M, Michalowska A, Majka M, Kucia M, Maslankiewicz K, . Mobilization of CD34/CXCR4+, CD34/CD117+, c-met+ stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction. Circulation. 2004;110:3213–20.
- Roberts N, Xiao Q, Weir G, Xu Q, Jahangiri M. Endothelial progenitor cells are mobilized after cardiac surgery. Ann Thorac Surg. 2007;83:598–605.
- Yin Y, Zhao X, Fang Y, Yu S, Zhao J, Song M, Huang L. SDF-1alpha involved in mobilization and recruitment of endothelial progenitor cells after arterial injury in mice. Cardiovasc Pathol. 2009. In press.
- Wang Y, Johnsen HE, Mortensen S, Bindslev L, Ripa RS, Haack-Sorensen M, . Changes in circulating mesenchymal stem cells, stem cell homing factor, and vascular growth factors in patients with acute ST elevation myocardial infarction treated with primary percutaneous coronary intervention. Heart. 2006;92:768–74.
- Dai Y, Ashraf M, Zuo S, Uemura R, Dai YS, Wang Y, . Mobilized bone marrow progenitor cells serve as donors of cytoprotective genes for cardiac repair. J Mol Cell Cardiol. 2008;44:607–17.
- Brehm M, Ebner P, Picard F, Urbien R, Turan G, Strauer BE. Enhanced mobilization of CD34(+) progenitor cells expressing cell adhesion molecules in patients with STEMI. Clin Res Cardiol. 2009;98:477–86.
- Norol F, Merlet P, Isnard R, Sebillon P, Bonnet N, Cailliot C, . Influence of mobilized stem cells on myocardial infarct repair in a nonhuman primate model. Blood. 2003;102:4361–8.
- Ellis SG, Penn MS, Bolwell B, Garcia M, Chacko M, Wang T, . Granulocyte colony stimulating factor in patients with large acute myocardial infarction: results of a pilot dose-escalation randomized trial. Am Heart J. 2006; 152:1051–14.
- Wang Y, Ripa RS, Jorgensen E, Hesse B, Mortensen S, Kastrup J. Mobilization of haematopoietic and non-haematopoietic cells by granulocyte-colony stimulating factor and vascular endothelial growth factor gene therapy in patients with stable severe coronary artery disease. Scand Cardiovasc J. 2007;41:397–404.
- Kassis I, Zangi L, Rivkin R, Levdansky L, Samuel S, Marx G, . Isolation of mesenchymal stem cells from G-CSF-mobilized human peripheral blood using fibrin microbeads. Bone Marrow Transplant. 2006;37:967–76.
- Liu ZJ, Zhuge Y, Velazquez OC. Trafficking and differentiation of mesenchymal stem cells. J Cell Biochem. 2009; 106:984–91.
- Mansilla E, Marin GH, Drago H, Sturla F, Salas E, Gardiner C, . Bloodstream cells phenotypically identical to human mesenchymal bone marrow stem cells circulate in large amounts under the influence of acute large skin damage: new evidence for their use in regenerative medicine. Transplant Proc. 2006;38:967–9.
- Zvaifler NJ, Marinova-Mutafchieva L, Adams G, Edwards CJ, Moss J, Burger JA, . Mesenchymal precursor cells in the blood of normal individuals. Arthritis Res. 2000;2:477–88.
- Tatsumi K, Otani H, Sato D, Enoki C, Iwasaka T, Imamura H, . Granulocyte-colony stimulating factor increases donor mesenchymal stem cells in bone marrow and their mobilization into peripheral circulation but does not repair dystrophic heart after bone marrow transplantation. Circ J. 2008;72:1351–8.
- Lund TC, Tolar J, Orchard PJ. Granulocyte colony-stimulating factor mobilized CFU-F can be found in the peripheral blood but have limited expansion potential. Haematologica. 2008;93:908–12.
- Ripa RS, Haack-Sorensen M, Wang Y, Jorgensen E, Mortensen S, Bindslev L, . Bone marrow derived mesenchymal cell mobilization by granulocyte-colony stimulating factor after acute myocardial infarction: results from the Stem Cells in Myocardial Infarction (STEMMI) trial. Circulation. 2007;116:I24–30.
- Kong D, Melo LG, Gnecchi M, Zhang L, Mostoslavsky G, Liew CC, . Cytokine-induced mobilization of circulating endothelial progenitor cells enhances repair of injured arteries. Circulation. 2004;110:2039–46.
- Case J, Mead LE, Bessler WK, Prater D, White HA, Saadatzadeh MR, . Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. Exp Hematol. 2007;35:1109–18.
- Yoder MC, Mead LE, Prater D, Krier TR, Mroueh KN, Li F, . Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood. 2007;109:1801–9.
- Orlic D, Kajstura J, Chimenti S, Limana F, Jakoniuk I, Quaini F, . Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci USA. 2001;98:10344–9.
- Ince H, Petzsch M, Kleine HD, Schmidt H, Rehders T, Korber T, . Preservation from left ventricular remodeling by front-integrated revascularization and stem cell liberation in evolving acute myocardial infarction by use of granulocyte-colony-stimulating factor (FIRSTLINE-AMI). Circulation. 2005;112:3097–106.
- Ai G, Su Y, Yan G, Wang M, Liu X, Xu H, . [The experimental study of bone marrow mesenchymal stem cells on the repair of skin wound combined with local radiation injury]. Zhonghua Yi Xue Za Zhi. 2002;82:1632–6.
- Cheng Z, Liu X, Ou L, Zhou X, Liu Y, Jia X, . Mobilization of mesenchymal stem cells by granulocyte colony-stimulating factor in rats with acute myocardial infarction. Cardiovasc Drugs Ther. 2008;22:363–71.
- Sesti C, Hale SL, Lutzko C, Kloner RA. Granulocyte colony-stimulating factor and stem cell factor improve contractile reserve of the infarcted left ventricle independent of restoring muscle mass. J Am Coll Cardiol. 2005;46:1662–9.
- Sugano Y, Anzai T, Yoshikawa T, Maekawa Y, Kohno T, Mahara K, . Granulocyte colony-stimulating factor attenuates early ventricular expansion after experimental myocardial infarction. Cardiovasc Res. 2005;65:446–56.
- Harada M, Qin Y, Takano H, Minamino T, Zou Y, Toko H, . G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes. Nat Med. 2005;11:305–11.
- Iwanaga K, Takano H, Ohtsuka M, Hasegawa H, Zou Y, Qin Y, . Effects of G-CSF on cardiac remodeling after acute myocardial infarction in swine. Biochem Biophys Res Commun. 2004;325:1353–9.
- Takahama H, Minamino T, Hirata A, Ogai A, Asanuma H, Fujita M, . Granulocyte colony-stimulating factor mediates cardioprotection against ischemia/reperfusion injury via phosphatidylinositol-3-kinase/Akt pathway in canine hearts. Cardiovasc Drugs Ther. 2006;20:159–65.
- Ueda K, Takano H, Hasegawa H, Niitsuma Y, Qin Y, Ohtsuka M, . Granulocyte colony stimulating factor directly inhibits myocardial ischemia-reperfusion injury through Akt-endothelial NO synthase pathway. Arterioscler Thromb Vasc Biol. 2006;26:e108–13.
- Engelmann MG, Theiss HD, Hennig-Theiss C, Huber A, Wintersperger BJ, Werle-Ruedinger AE, . Autologous bone marrow stem cell mobilization induced by granulocyte colony-stimulating factor after subacute ST-segment elevation myocardial infarction undergoing late revascularization: final results from the G-CSF-STEMI (Granulocyte Colony-Stimulating Factor ST-Segment Elevation Myocardial Infarction) trial. J Am Coll Cardiol. 2006;48:1712–21.
- Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M, . Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med. 1999;5:434–8.
- Brunner S, Huber BC, Fischer R, Groebner M, Hacker M, David R, . G-CSF treatment after myocardial infarction: impact on bone marrow-derived vs cardiac progenitor cells. Exp Hematol. 2008;36:695–702.
- Kuznetsov SA, Mankani MH, Gronthos S, Satomura K, Bianco P, Robey PG. Circulating skeletal stem cells. J Cell Biol. 2001;153:1133–40.
- Roberts AW, Foote S, Alexander WS, Scott C, Robb L, Metcalf D. Genetic influences determining progenitor cell mobilization and leukocytosis induced by granulocyte colony-stimulating factor. Blood. 1997;89:2736–44.
- Lucas D, Battista M, Shi PA, Isola L, Frenette PS. Mobilized hematopoietic stem cell yield depends on species-specific circadian timing. Cell Stem Cell. 2008;3:364–6.